Blueshift Asset Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-16,585
Closed -$302K 1197
2021
Q4
$302K Sell
16,585
-17,175
-51% -$371K 0.03% 626
2021
Q3
$660K Buy
+33,760
New +$1.28M 0.04% 536

Other funds holding CELL

Blueshift Asset Management's CELL Position: Q1 2022 in Review

Blueshift Asset Management sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2022, closing a stake of 16,585 shares — an estimated $302K sold.

Blueshift Asset Management first reported a position in CELL in Q3 2021 and held it in 2 quarters. The position peaked at $660K in Q3 2021. 130 funds tracked by Wall St. Rank hold CELL as of Q1 2022.

  • Blueshift Asset Management reported no remaining PhenomeX Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Blueshift Asset Management sold 16,585 PhenomeX Inc. Common Stock shares in Q1 2022, an estimated $302K.
  • Blueshift Asset Management first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Blueshift Asset Management's PhenomeX Inc. Common Stock position peaked at $660K in Q3 2021.
  • 130 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2022.

Based on Blueshift Asset Management's 13F filing for Q1 2022, filed 12 May 2022.